Health SystemsHelix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse PopulationsNovember 13, 2024
Health SystemsHelix to Showcase the Impact of Clinico-Genomic Research on Clinical Care and Drug Discovery at ASHG Annual MeetingOctober 30, 2024
Population GenomicsSan Diego startup Helix uses pandemic success to push healthcare into the futureJune 16, 2023
Population GenomicsTwist and Shout: Helix is Weaving Population Genomics into the Healthcare FabricApril 27, 2023
EducationOn DNA Day, Honoring the Pioneers who Laid the Foundation for Population GenomicsApril 24, 2023
Company NewsHelix recognized as "Top Genomics Company Accelerating Research and Discovery"August 29, 2022
Helix PartnersHelix, Memorial Hermann Health System partner on population genomics projectJune 29, 2022
Company NewsHelix Expands Leadership Team to Support Rapid Growth into New Segments of HealthcareJanuary 5, 2022
Public HealthHow DNA-testing startup Helix became one of the nation's leading coronavirus tracking labsJune 14, 2021
Company NewsHelix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral SurveillanceJune 3, 2021
Company NewsMarc Stapley Assumes Role of Executive Chairman of the Board of Directors of Helix; President and Co-founder James Lu Appointed President and Chief Executive OfficerMay 6, 2021
Company NewsHelix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk TestJanuary 11, 2021
